Journal of Liver Cancer

Review Article

Preventing false positive imaging diagnosis of HCC: differentiating HCC from mimickers and practical strategies: Ijin Joo; J Liver Cancer. 2025;25(2):217-232. Published online July 31, 2025; DOI: https://doi.org/10.17998/jlc.2025.07.29

9,907 Views
138 Downloads
4 Web of Science
7 Citations

Noninvasive imaging-based diagnosis of hepatocellular carcinoma (HCC) in high-risk patients plays a central role in clinical practice. Current major guidelines typically rely on the radiologic hallmark of nonrim arterial phase hyperenhancement followed by nonperipheral washout, criteria designed to achieve both high positive predictive value and sufficient specificity when applied within well-defined target populations. Despite these criteria, false positive diagnoses still occur and can lead to unnecessary or inappropriate treatment, as various benign and non-HCC malignant lesions may exhibit vascular features that overlap with the classic appearance of HCC. Furthermore, treatment decisions are occasionally guided by imaging findings even in patients outside the target population who are being evaluated for possible HCC, in whom vascular patterns are less specific and the risk of false positive diagnosis is inherently higher. Minimizing the risk of false positive diagnosis requires not only adherence to validated imaging criteria but also clinical and contextual integration when findings are uncertain. This includes consideration of ancillary features, tumor markers, and, when appropriate, further evaluation through biopsy, additional imaging, or follow-up. This review outlines a range of HCC mimickers and provides practical strategies to support accurate imaging interpretation and reduce false positive diagnoses in clinical practice.

Citations

Citations to this article as recorded by

Diagnostic Accuracy of Extracellular versus Hepatobiliary Contrast-enhanced MRI in LI-RADS Nonradiation Treatment Response Algorithm Version 2024
Subin Heo, Yong Jun Jung, Eun Sun Choi, Sehee Kim, Kyoung Won Kim, Young-In Yoon, Hyung Jin Won, Yong Moon Shin, Dong Hwan Kim, Sang Hyun Choi
Radiology.2026;[Epub] CrossRef
“WBC-HBP Dissociation” Unveils Occult Xanthogranulomatous Inflammation Mimicking Hepatocellular Carcinoma in Diabetic Patients
Xuan-Yi Zhu, Kai-Chi Liu, Ze-Bin Zhu, Shu-Geng Zhang
Journal of Hepatocellular Carcinoma.2026; Volume 13: 1. CrossRef
Gadoxetate-enhanced MRI Transitional Phase Parenchymal Signal: Effect on Washout and LI-RADS Diagnostic Performance for Hepatocellular Carcinoma
Seong Hyeon Cho, Yong Jun Jung, Seung Baek Hong, Se Jin Choi, Seung Soo Lee, Jae Ho Byun, Hyung Jin Won, Yong Moon Shin, Subin Heo, Sang Hyun Choi
Radiology.2026;[Epub] CrossRef
Imaging differentiation of hepatocellular carcinoma, combined hepatocellular-cholangiocarcinoma, and intrahepatic cholangiocarcinoma: pitfalls and advances
Jaeseung Shin, Taek Chung, Sang Yun Ha, Hyungjin Rhee
Journal of Liver Cancer.2026; 26(1): 9. CrossRef
Advances in the Management of Hepatocellular Carcinoma: Evolving Systemic Therapy, Perioperative Strategies, and Care for Special Populations
Jing He, Xiao-Qin Wu, Zhen-Guang Wang
Journal of Clinical Question.2026;[Epub] CrossRef
Focal Nodular Hyperplasia Mimicking Hepatocellular Carcinoma in Chronic Hepatitis B Represents a Diagnostic Pitfall
Tom Ryu, Soung Won Jeong, Young Chang, Jae Young Jang
Clinical Ultrasound.2026; 11(1): 80. CrossRef
Advances in the imaging of liver cancer
Ijin Joo, Jeong Min Lee, Maxime Ronot
Journal of Hepatology.2026;[Epub] CrossRef

First
Prev
Page of 1
Next
Last

Search